Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11338020 Alkaline phosphatase agents for treatment of neurodevelopmental disorders

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Synthetic Biologics, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

May 24, 2022

Patent Application Number

16960362

Date Filed

January 8, 2019

Patent Citations

US Patent 10603361 Methods of treating a subject with an alkaline phosphatase deficiency

US Patent 10570380 Downstream processing of an alkaline phosphatase

US Patent 10987410 Alkaline phosphatase formulations

US Patent 10000532 Bone delivery conjugates and method of using same to target proteins to bone

US Patent 10052366 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof

US Patent 10449236 Treating seizure with recombinant alkaline phosphatase

Patent Primary Examiner

Ralph J Gitomer

Compositions and methods, including therapeutic alkaline phosphatases that find use in the treatment or prevention of various neurodevelopmental diseases or disorders, are described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11338020 Alkaline phosphatase agents for treatment of neurodevelopmental disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool